ALT logo

Altimmune (ALT) Return On Equity

ALT Annual ROE

-46.63%
-2.56%-5.81%

31 December 2023

ALT ROE Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ALT Quarterly ROE

-64.43%
-3.94%-6.51%

30 September 2024

ALT Quarterly ROE Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ALT ROE Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-5.8%-26.1%
3 y3 years-29.0%-72.5%
5 y5 years+42.3%+20.4%

ALT ROE High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-5.8%at low-48.9%at low
5 y5-year-29.0%at low-87.9%+1.6%
alltimeall time-9616.3%+89.7%-106.5%+98.9%

Altimmune ROE History

DateAnnualQuarterly
Sept 2024
-
-64.43%(+6.5%)
June 2024
-
-60.49%(+11.2%)
Mar 2024
-
-54.38%(+6.4%)
Dec 2023
-46.63%(+5.8%)
-51.11%(+14.1%)
Sept 2023
-
-44.78%(+1.4%)
June 2023
-
-44.18%(-3.0%)
Mar 2023
-
-45.53%(+4.1%)
Dec 2022
-44.07%(-3.5%)
-43.72%(-0.1%)
Sept 2022
-
-43.78%(-7.0%)
June 2022
-
-47.10%(+0.2%)
Mar 2022
-
-47.02%(+8.7%)
Dec 2021
-45.69%(+26.4%)
-43.27%(+15.9%)
Sept 2021
-
-37.34%(+8.9%)
June 2021
-
-34.29%(-9.3%)
Mar 2021
-
-37.82%(-8.6%)
Dec 2020
-36.14%(-17.4%)
-41.39%(-19.0%)
Sept 2020
-
-51.10%(-21.9%)
June 2020
-
-65.47%(+48.1%)
Mar 2020
-
-44.20%(+11.5%)
Dec 2019
-43.74%(-45.8%)
-39.65%(-51.0%)
Sept 2019
-
-80.92%(+20.0%)
June 2019
-
-67.42%(-18.5%)
Mar 2019
-
-82.77%(-7.2%)
Dec 2018
-80.77%(-29.6%)
-89.23%(+73.4%)
Sept 2018
-
-51.47%(-46.7%)
June 2018
-
-96.49%(+5.6%)
Mar 2018
-
-91.40%(-8.7%)
Dec 2017
-114.79%(+152.9%)
-100.06%(+57.4%)
Sept 2017
-
-63.59%(+134.6%)
June 2017
-
-27.10%(-12.6%)
Mar 2017
-
-31.02%(+30.5%)
Dec 2016
-45.39%(+130.4%)
-23.77%(+12.8%)
Sept 2016
-
-21.08%(-27.9%)
June 2016
-
-29.22%(-15.8%)
Mar 2016
-
-34.71%(+83.6%)
Dec 2015
-19.70%
-18.91%(-27.7%)
Sept 2015
-
-26.14%(-45.0%)
June 2015
-
-47.52%(+15.3%)
DateAnnualQuarterly
Mar 2015
-
-41.23%(-47.9%)
Dec 2014
-77.75%(-36.9%)
-79.13%(-24.6%)
Sept 2014
-
-104.94%(-3.1%)
June 2014
-
-108.30%(-8.4%)
Mar 2014
-
-118.23%(+8.0%)
Dec 2013
-123.29%(+244.9%)
-109.46%(+50.2%)
Sept 2013
-
-72.89%(+83.8%)
June 2013
-
-39.65%(+12.0%)
Mar 2013
-
-35.39%(-3.0%)
Dec 2012
-35.75%(+32.1%)
-36.50%(+76.8%)
Sept 2012
-
-20.65%(+9.0%)
June 2012
-
-18.95%(-40.5%)
Mar 2012
-
-31.87%(+13.3%)
Dec 2011
-27.07%(-94.0%)
-28.13%(-89.1%)
Sept 2011
-
-257.53%(-66.8%)
June 2011
-
-776.51%(-86.3%)
Mar 2011
-
-5679.71%(-670.5%)
Dec 2010
-453.67%(+55.4%)
995.50%(+135.8%)
Sept 2010
-
422.14%(-112.8%)
June 2010
-
-3289.10%(+502.5%)
Mar 2010
-
-545.88%(+87.7%)
Dec 2009
-291.92%(+138.6%)
-290.77%(+16.1%)
Sept 2009
-
-250.38%(+62.0%)
June 2009
-
-154.60%(-19.4%)
Mar 2009
-
-191.75%(+28.0%)
Dec 2008
-122.33%(+74.3%)
-149.80%(+20.9%)
Sept 2008
-
-123.86%(+48.0%)
June 2008
-
-83.70%(+177.2%)
Mar 2008
-
-30.19%(+39.1%)
Dec 2007
-70.18%(+25.8%)
-21.71%(+9.0%)
Sept 2007
-
-19.91%(-38.3%)
June 2007
-
-32.28%(+28.3%)
Mar 2007
-
-25.15%(+37.4%)
Dec 2006
-55.79%(<-9900.0%)
-18.31%(+239.1%)
Sept 2006
-
-5.40%(-415.8%)
June 2006
-
1.71%(+48.7%)
Mar 2006
-
1.15%(+53.3%)
Dec 2005
0.49%
0.75%(+44.2%)
Sept 2005
-
0.52%

FAQ

  • What is Altimmune annual return on equity?
  • What is the all time high annual ROE for Altimmune?
  • What is Altimmune annual ROE year-on-year change?
  • What is Altimmune quarterly return on equity?
  • What is the all time high quarterly ROE for Altimmune?
  • What is Altimmune quarterly ROE year-on-year change?

What is Altimmune annual return on equity?

The current annual ROE of ALT is -46.63%

What is the all time high annual ROE for Altimmune?

Altimmune all-time high annual return on equity is 0.49%

What is Altimmune annual ROE year-on-year change?

Over the past year, ALT annual return on equity has changed by -2.56% (-5.81%)

What is Altimmune quarterly return on equity?

The current quarterly ROE of ALT is -64.43%

What is the all time high quarterly ROE for Altimmune?

Altimmune all-time high quarterly return on equity is 995.50%

What is Altimmune quarterly ROE year-on-year change?

Over the past year, ALT quarterly return on equity has changed by -13.32% (-26.06%)